Empowering Cancer Treatment With Radionuclide Therapy

1. Empowering Cancer Treatment With Radionuclide Therapy What is Radionuclide therapy Radionuclide therapy, commonly known as targeted radiotherapy, is a medical treatment that uses radioactive chemicals to target cancer cells or diseased tissue with precise radiation. It involves injecting radiopharmaceuticals, which are substances containing radionuclides, into the patient's body. Due to their unique biological characteristics, these radiopharmaceuticals can selectively target cells or tissues. Once inside the body, radionuclides release radiation that destroys the DNA of targeted cells, causing them to die. Radionuclide therapy is widely used to treat cancers such as thyroid cancer, prostate cancer, and neuroendocrine tumors. It has several advantages over conventional radiation therapy, including the ability to directly target cancer cells while sparing healthy organs. This focused approach minimizes negative effects while increasing treatment efficacy. The radionuclide used and the method of delivery vary depending on the type and stage of the cancer. Overall, radionuclide therapy is a potential treatment option that is evolving and contributing to improved cancer treatment outcomes. Types of Radionuclide therapy

2. Radionuclide therapy is a form of targeted treatment that uses radioactive substances to deliver radiation directly to cancer cells or specific disease sites.  Iodine-131 (I-131) therapy: I This is commonly used to treat thyroid cancer. The radioactive iodine is taken up by thyroid cells and destroys them through the emission of beta particles.  Lutetium-177 (Lu-177) therapy: It is used for the treatment of neuroendocrine tumors and prostate cancer. Lu-177 emits beta particles that selectively kill cancer cells while sparing healthy tissue.  Yttrium-90 (Y-90) therapy: This therapy is used to treat liver cancer (hepatocellular carcinoma) and metastatic tumors in the liver. Y-90 emits high-energy beta particles that target and destroy cancer cells in the liver.  Radium-223 (Ra-223) therapy: This is especially used to treat bone metastases in patients with advanced prostate cancer. Ra-223 emits alpha particles that deliver localized radiation to bone metastases, reducing pain and improving survival. These radionuclide therapies provide an effective treatment option with fewer side effects than conventional therapies, making them valuable in the management of certain cancers and related conditions. It is crucial to do the medication and therapy with a renowned radionuclide therapy center for better treatment. The RNM Center is a nuclear medicine and radiation therapy in Rohtak, Haryana, India. Dr. Parveen Kundu, a nuclear medicine specialist with over 8 years of expertise, established the center in 2018. The RNM center is the first nuclear medicine center in Rohtak and the first center in Haryana (outside the National Capital Region) to offer radionuclide therapy. The Center provides a broad range of nuclear medicine services. Conclusion Radionuclide therapy is an effective treatment option for cancer and other diseases. It uses radioactive chemicals to deliver targeted radiation to cancer cells, resulting in effective treatment with fewer side effects than conventional treatments. RNM center in Haryana is one such facility which provides these services. The center specializes in radiation therapy and has state-of-the- art facilities for cancer diagnosis and treatment. RNM Center with a dedicated team of medical professionals and innovative technologies aims at providing holistic treatment to the patients focusing on their well-being and recovery. To cure cancer and improve their quality of life, patients can benefit from the experience of skilled oncologists as well as the most recent breakthroughs in radionuclide therapy. CONTACT US RNM Address: Rohtak Nuclear Medcare, Vinay Nagar Gali No 5, Opp Tau Devi Lal Park, Main Delhi Northern Highway, Rohtak, India, Haryana https://rnmcenter.com/

3. 083073 5562 info@rnmcenter.com